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Abstract
Background: Psychotropic drugs are commonly utilised among the elderly. This study aimed to analyse whether two 
socioeconomic determinants - income and marital status - are associated with differences in utilisation of psychotropic 
drugs and potentially inappropriate psychotropic drugs among elderly in Sweden.
Methods: All individuals aged 75 years and older who had purchased a psychotropic drug in Sweden during 2006 
were included (68.7% women, n = 384712). Data was collected from national individual-based registers. Outcome 
measures were utilisation of three or more psychotropic drugs and utilisation of potentially inappropriate psychotropic 
drugs, as classified by the Swedish National Board of Health and Welfare.
Results: Individuals with low income were more likely to utilise three or more psychotropic drugs compared to those 
with high income; adjusted odds ratio (aOR) 1.12 (95% confidence interval [CI] 1.10-1.14). The non-married had a 
higher probability for utilising three or more psychotropic drugs compared to the married (aOR 1.22; CI 1.20-1.25). The 
highest probability was observed among the divorced and the never married. Potentially inappropriate psychotropic 
drugs were more common among individuals with low compared to high income (aOR 1.14; CI 1.13-1.16). Compared 
to the married, potentially inappropriate psychotropic drug utilisation occurred more commonly among the non-
married (aOR 1.08; CI 1.06-1.10). The never married and the divorced had the highest probability.
Conclusions: There was an association between socioeconomic determinants and psychotropic drug utilisation. The 
probability for utilising potentially inappropriate psychotropics was higher among individuals with low income and 
among the non-married.
Background
Psychotropic drugs are common among the elderly and rep-
resent a considerable proportion of inappropriate drugs
used in this population [1]. The elderly are especially vul-
nerable to drug-related adverse health outcomes, and expo-
sure to inappropriate drugs is associated with an increased
risk of such events [2]. Socioeconomic determinants (e.g.,
poverty and lack of social support) influence health. Low
socioeconomic status is associated with a higher prevalence
of overall morbidity, including psychiatric morbidity [3-5],
but also a decreased access to high-quality care and a lower
consumer demand [6,7]. Further, marital status and social
support is associated with health and health behaviour [8-
10].
Health care quality differs between socioeconomic
groups, particularly regarding the extent of preventive care,
the cost of treatment procedures, and appropriate drug utili-
sation [6,11-13]. However, research focusing on the associ-
ation between socioeconomic determinants, psychotropic
drugs, and potentially inappropriate psychotropic drugs
among the elderly is scarce [1,14]. Explicit criteria on
potentially inappropriate drugs among the elderly often
focus on pharmacological appropriateness, such as choice
of drug, dose, drug interactions, duplications, and duration
of drug therapy [15]. The Swedish National Board of
Health and Welfare (NBHW) has published a list of quality
indicators and explicit criteria for measuring inappropriate
drug utilisation among the elderly in Sweden [16]. The list
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and internationally published explicit criteria such as Beers'
criteria [17].
The introduction of the Swedish Prescribed Drug Regis-
ter in 2005 [18] enabled linkage of information on drug util-
isation and social determinants on an individual level with
complete national coverage. This study aimed to analyse
whether two socioeconomic determinants - income and
marital status - are associated with differences in utilisation
of psychotropic drugs and potentially inappropriate psycho-
tropic drugs (PIP) among the elderly in Sweden.
Methods
Study participants and data sources
The study participants encompassed all individuals aged 75
years and older on 1 January 2006 in Sweden who had pur-
chased a prescribed psychotropic drug in 2006 (n =
384712). Data on dispensed prescription drugs was
obtained from the national individual-based Swedish Pre-
scribed Drug Register held at the National Board of Health
and Welfare [18]. The register includes all prescribed drugs
purchased at Swedish pharmacies, but not drugs utilised in
hospitals or purchased over the counter. Information on the
participants' age, sex and all purchased prescription drugs
(type, amount and date of purchase) was collected. In Swe-
den, co-payment for reimbursed drugs is independent of
income. The maximum co-payment for prescription drugs
within the pharmaceutical benefits scheme is SEK 1800
(SEK 1 = n0.106 on 1 January 2006) per twelve month
period (Act 2002:160 on Pharmaceutical Benefits, etc.).
Data from the Swedish Prescribed Drug Register was
linked to the LISA database (the longitudinal integration
database for health insurance and labour market studies;
held at Statistics Sweden) via the unique person identifica-
tion number. Information regarding family disposable
income, number of family members, marital status, country
of birth and date of death and migration was collected from
the LISA database. The project was approved by the
regional ethics board in Gothenburg, Sweden (No. 054-07).
Drugs were classified according to the Anatomical Thera-
peutic Chemical (ATC) classification system [19]. Psycho-
tropic drugs were categorised as follows: any psychotropic
(ATC-codes N05 and N06), antipsychotics (N05A), anxi-
olytics (N05B), hypnotics (N05C), and antidepressants
(N06A).
Socioeconomic determinants
Income was calculated using the square root scale (i.e.,
family disposable income during 2005 divided by the
square root of the number of family members) [20,21]. The
study participants were categorised into income tertiles to
focus on any differences between those with the lowest
income compared to those with the highest income. For
analyses stratified by sex, this categorisation was per-
formed separately for men and women. Marital status on 31
December 2006 was categorised as married, never married,
divorced, or widowed. Country of birth was included as a
potential confounder and categorised as Sweden, other Nor-
dic countries, other European countries, and outside
Europe. The number of unique nonpsychotropic drug sub-
stances purchased during the study period was used as a
proxy for health care utilisation and comorbidity [22].
Outcome measures
The number of unique psychotropic drugs purchased during
2006 was dichotomised into three or more vs. less than
three psychotropic drugs. Utilisation of three or more psy-
chotropic drugs was considered to reflect an increased
exposure to psychotropic drugs. PIP was defined as the util-
isation of potentially inappropriate psychotropic substances
(PIPS) or potentially inappropriate combinations of psycho-
tropics (PICP), as classified by the NBHW [16]. PIPS was
defined as at least one purchase of long-acting benzodiaz-
epines (flunitrazepam, nitrazepam, and diazepam), anticho-
linergic psychotropics, propiomazine, or triazolam during
2006. PICP was defined as concurrent utilisation of two or
more benzodiazepines, two or more psychotropics in the
same class (e.g., two or more hypnotics), and two or more
anticholinergic psychotropics for a total of 40 days during
2006. The estimation of concurrent drug utilisation has
been described previously [23]. Briefly, information on pre-
scribers' dosage instructions is available only as a free text
section in the register and is therefore not statistically pro-
cessable. A review of prescribed daily doses (PDDs) was
performed for a random sample of dispensed prescriptions
for each substance. Substance-specific population average
PDDs were estimated for each psychotropic substance, thus
enabling the calculation of theoretical treatment periods
based on date of purchase and purchased amount. A
detailed description of PIP and associated prevalence rates
have been reported previously [23].
Statistical analyses
A person-year proportion, defined as the proportion of days
resident in the country and alive during 2006, was calcu-
lated for each individual. For example, the person-year pro-
portion for an individual who died on 26 March 2006 was
0.23 (84/365 days). The person-year proportion was
included in the regression models, thereby taking date of
death or migration into account. Further, the sum of the per-
son-year proportions was used as the denominator when
calculating the prevalence of utilisation of three or more
psychotropic drugs and of PIP among the study partici-
pants.
Simple and multiple logistic regression analyses were
performed for the outcome measures of three or more psy-
chotropic drugs and PIP. The multiple logistic regression
models included income or marital status, age, sex, country
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stances purchased during the study period, and the person-
year proportion (not included in analyses on marital status).
All regression analyses were also performed stratified by
age and sex. Due to partially missing data, 366 individuals
were excluded from the regression analyses including
income. Marital status was recorded at the end of 2006 and
was therefore missing for the 40880 individuals who died
and the 77 who migrated during the study period. Further,
the regression analyses were repeated in a 10% random
sample, since the risk of false positive results increases as
the sample size increases.
Simple and multiple Poisson regression analyses were
performed for count outcomes (number of psychotropic
drugs and number of PIP). The results from the Poisson
regression analyses were in agreement with the logistic
regression analyses, and are therefore not presented. Chi-
square tests were used to compare proportions. The level
for statistical significance was 0.05. SAS version 9.1.3
(SAS Institute, NC) was used for data management, and
Stata version 10.1 (StataCorp, TX) was used for statistical
analyses.
Results
Table 1 includes the characteristics of the study partici-
pants. Individuals with low income had n12003 or less, and
those with high income had n15171 or more. Among those
who purchased psychotropic drugs, median income was
n14937 for men and n12620 for women. In the entire Swed-
ish population aged 75 years and older (n = 800129),
median income was n17352 for men and n13546 for
women (source: Statistics Sweden). The proportion of mar-
ried individuals was lower among psychotropic drug users
than in the corresponding entire Swedish population (men
60.8% [189616/311796], women 27.5% [133955/487305];
source: Statistics Sweden).
Among the study participants aged 75-79 years, 22.5%
(25828/114401) had low income; among individuals aged
85 years and older, the corresponding proportion was
43.7% (65422/149682). Death or migration occurred more
commonly among individuals aged 85 years or older com-
pared to 75-79 years (16.6% vs. 5.4%; p < 0.001), among
those with low compared to high income (12.9% vs. 8.8%;
p < 0.001), and among men compared to women (13.8%
[16610] vs. 9.2% [24347]; p < 0.001) (Table 1).
Among elderly psychotropic drug users, 22.1% (85182)
had purchased three or more psychotropic drugs during
2006. Individuals who died or migrated during the study
period were more likely to utilise three or more psychotro-
pic drugs compared to those who survived and did not
migrate (31.8% [13019] vs. 21.0% [72163]; p < 0.001).
Older age, female sex, and low income were associated
with a higher probability for utilising three or more psycho-
tropic substances (Table 2).
Among individuals with low income, the adjusted odds
ratio (aOR) for utilising three or more psychotropic drugs
was 1.34 (95% confidence interval [CI] 1.26-1.43; refer-
ence: high income) for men aged 75-79 years, and 0.99 (CI
0.93-1.05) among men aged 85 years or more. For women,
the corresponding aORs were 1.23 (CI 1.17-1.28) in the
younger age group and 1.03 (CI 0.99-1.07) in the older age
group.
Compared to married individuals, the never married, the
divorced and the widows/widowers showed a higher proba-
bility for utilising three or more psychotropic drugs (Table
3). Men who were never married and divorced women
showed the highest probability for utilising three or more
psychotropic drugs. The associations were more pro-
nounced among younger rather than older elderly (data not
shown).
PIPS were utilised by 36.0% (138467), and PICP by
12.2% (46746); 9.0% (34596) utilised PIPS as well as
PICP. Thus, PIP were utilised by 39.2% (150617). PIP utili-
sation occurred more commonly among those who died or
migrated during the study period compared to those who
survived and did not migrate (42.2% [17274] vs. 38.8%
[133343]; p < 0.001, respectively). Older age and female
sex were inversely associated with PIP utilisation, while
low income was associated with a higher probability for
PIP utilisation (Table 4). The probability for utilising PIPS
and PICP, respectively, was higher among individuals with
low income (PIPS: aOR 1.14; CI 1.12-1.16; PICP: aOR
1.11; CI 1.08-1.14; reference: high income). The aOR for
having both PIPS and PICP was 1.12 (1.09-1.15) among
individuals with low income compared to those with high
income.
The aOR among men with low income was 1.23 (95% CI
1.17-1.30; reference: high income) in the younger age
group, and 1.14 (1.08-1.20) in the older age group. For
women, the corresponding aORs were 1.13 (1.09-1.18) and
1.09 (1.05-1.12), respectively.
Never married and divorced individuals were more likely
to utilise PIP compared to married individuals (Table 5).
The probability for PIP utilisation was marginally higher
among widows/widowers. These associations were more
pronounced among the younger than the older elderly (data
not shown). The aOR for having both PIPS and PICP was
1.51 (1.44-1.59) among the never married, 1.41 (1.36-1.47)
among the divorced, and 1.14 (1.11-1.18) among the wid-
ows/widowers, as compared to the married.
The regression analyses performed in the 10% random
sample gave similar results as the original analyses, with
two exceptions. The middle income group and the widows/
widowers did not have a statistically significant higher
probability for utilisation of PIP in the adjusted analyses (p
= 0.08 and p = 0.66, respectively).
Lesén et al. BMC Public Health 2010, 10:118
http://www.biomedcentral.com/1471-2458/10/118
Page 4 of 9Discussion
The present study showed a higher likelihood for utilising
several psychotropics as well as PIP among individuals
with low income and among the non-married. While the
magnitudes of the higher probabilities were fairly small,
they still indicate that socioeconomic determinants are
Table 1: Characteristics of the study participants.
Men (n = 120426) Women (n = 264286) Total (n = 384712) Death/migration, No. 
(Row %)
Age
75-79 years, No. 
(%)
39636 (32.9) 74932 (28.4) 114568 (29.8) 6128 (5.4)
80-84 years, No. 
(%)
39728 (33.0) 80645 (30.5) 120373 (31.3) 9931 (8.3)
85+ years, No. (%) 41062 (34.1) 108709 (41.1) 149771 (38.9) 24898 (16.6)




21215 (33.0) 17457 (33.0) 18743 (33.0) 11106 (8.8)
Middle income, 
median (%)
14937 (33.8) 12620 (33.9) 13126 (33.9) 13438 (10.3)
Low income, 
median (%)
11748 (33.1) 10281 (33.0) 10632 (33.1) 16401 (12.9)
Missing, No. (%) 188 (0.2) 177 (0.1) 365 (0.1) 12 (3.3)
Marital status
Married, No. (%) 58376 (48.5) 58395 (22.1) 116772 (30.4) -
Never married, No. 
(%)
8400 (7.0) 13350 (5.1) 21750 (5.7) -
Divorced, No. (%) 10100 (8.4) 25646 (9.7) 35746 (9.3) -
Widowed, No. (%) 26814 (22.3) 142448 (53.9) 169262 (44.0) -
Missing, No. (%)† 16736 (13.9) 24446 (9.2) 41182 (10.7) 40957 (99.5)
Country of birth
Sweden, No. (%) 111738 (92.8) 241804 (91.5) 353542 (91.9) 38151 (10.8)
Other Nordic 
countries, No. (%)
3918 (3.3) 11852 (4.5) 15770 (4.1) 1429 (9.1)
Europe, No. (%) 3616 (3.0) 8232 (3.1) 11848 (3.1) 1067 (9.0)
Outside Europe, 
No. (%)
1130 (0.9) 2365 (0.9) 3495 (0.9) 310 (8.9)
Missing, No. (%) 24 (0.0) 33 (0.0) 57 (0.0) 0 (0.0)
Number of unique 
drugs
1-4, No. (%) 12219 (10.1) 26479 (10.0) 38698 (10.1) 2489 (6.4)
5-9, No. (%) 41504 (34.5) 91856 (34.8) 133360 (34.7) 12040 (9.0)
10+, No. (%) 66703 (55.4) 145951 (55.2) 212654 (55.3) 26428 (12.4)
Missing, No. (%) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
* Family disposable income for year 2005, adjusted for family size. SEK 1 = €.106 (1 January 2006).
† Marital status was missing for all individuals who died or migrated during 2006 (n = 40957). When these were excluded, marital status was 



















































Table 2: Age, sex and income and utilisation of three or more psychotropic drugs among the study participants 
(n = 384346).









75-79 22729/111787 (20.3) 1 (Reference) 1 (Reference)
80-84 26227/115802 (22.7) 1.12 (1.09-1.14) < 0.001 1.09 (1.07-1.11) < 0.001
85+ 36226/137798 (26.3) 1.25 (1.22-1.27) < 0.001 1.19 (1.16-1.21) < 0.001
Sex
Men 24671/112602 (21.9) 1 (Reference) 1 (Reference)
Women 60511/252786 (23.9) 1.17 (1.15-1.19) < 0.001 1.14 (1.12-1.16) < 0.001
Income*
High 25959/121784 (21.3) 1 (Reference) 1 (Reference)
Middle 29087/124009 (23.5) 1.11 (1.09-1.13) < 0.001 1.06 (1.04-1.08) < 0.001
Low 30075/119233 (25.2) 1.19 (1.17-1.21) < 0.001 1.12 (1.10-1.14) < 0.001
* Family disposable income for year 2005, adjusted for family size.
† The denominator was adjusted according to the proportion of days the population was resident in the country and alive during 2006
‡ Adjusted for the proportion of days resident in the country and alive during 2006
§ Adjusted for age, sex, income, country of birth, proportion of days resident in the country and alive during 2006, and number of unique nonpsychotropic drug substances purchased during 
the study period.
Lesén et al. BMC Public Health 2010, 10:118
http://www.biomedcentral.com/1471-2458/10/118
Page 6 of 9associated with differences in utilisation of psychotropic
drugs among the elderly. The magnitudes are comparable to
a previous Swedish study on inappropriate drug use and
education level among elderly [13]. These findings could
suggest structural problems in the health care system.
Individuals with low income and the non-married were
more likely to utilise three or more psychotropic drugs
compared to those with high income and married individu-
als, respectively. Previous research has shown that the more
vulnerable groups have an increased morbidity [4,5]. Infor-
mation on morbidity was not available for this study; how-
ever, our findings could correspond to the ambition of the
Swedish health care system to provide health care in rela-
tion to individual needs [24].
One of the cornerstones of the Swedish health care is that
good health care should be provided for the entire popula-
tion on equal terms [24]. Consequently, quality in drug
treatment should not differ between socioeconomic groups.
In this study, individuals with low income were more likely
to utilise psychotropic drugs classified as potentially inap-
propriate by the NBHW compared to those with high
income. These findings are consistent with previous studies
on socioeconomic determinants and drug utilisation in Swe-
den [13] and in other countries [11,25-27]. Physicians'
choice of drug may be influenced by patients' requests [28].
Since individuals in higher socioeconomic groups generally
have increased access to health and drug information [6],
they may be more likely to request drugs with a more
favourable risk-benefit profile. Previous research has
shown that individuals in higher socioeconomic groups are
more likely to utilise newly marketed and brand-name
drugs [26,29].
Marriage is positively associated with health and health
behaviour [8-10]. In a somewhat younger population,
divorced women and widowed men had an increased utili-
sation of psychotropic drugs compared to married or single
men and women [14]. Married individuals in our study
were less likely to utilise three or more psychotropic drugs
as well as PIP compared to non-married individuals. Previ-
ous research on the utilisation of potentially inappropriate
drugs and marital status or cohabitation is scarce and incon-
clusive [11,30]. The associations between marital status and
drug utilisation in this population were more pronounced
among men than among women, which may be related to
the higher health benefits gained from marriage among men
than among women [9,31].
Compared to women, men were less likely to utilise three
or more psychotropic substances, but more likely to utilise
Table 3: Marital status and utilisation of three or more psychotropic drugs among the study participants (n = 343530)*.
Utilisation of 





p-value Adjusted Odds 
Ratio (95% CI) †
p-value
Total (n = 343530)
Married 21238 (18.2) 1 (Reference) 1 (Reference)
Never married 5028 (23.1) 1.35 (1.31-1.40) < 0.001 1.35 (1.30-1.40) < 0.001
Divorced 8546 (23.9) 1.41 (1.37-1.45) < 0.001 1.35 (1.31-1.39) < 0.001
Widow/widower 37332 (22.1) 1.27 (1.25-1.30) < 0.001 1.17 (1.14-1.19) < 0.001
Men (n = 103690)
Married 10119 (17.3) 1 (Reference) 1 (Reference)
Never married 1897 (22.6) 1.39 (1.32-1.47) < 0.001 1.45 (1.37-1.54) < 0.001
Divorced 2165 (21.4) 1.30 (1.24-1.37) < 0.001 1.32 (1.25-1.39) < 0.001
Widow/widower 5489 (20.5) 1.23 (1.18-1.27) < 0.001 1.19 (1.15-1.24) < 0.001
Women (n = 239840)
Married 11119 (19.0) 1 (Reference) 1 (Reference)
Never married 3131 (23.5) 1.30 (1.25-1.36) < 0.001 1.28 (1.23-1.34) < 0.001
Divorced 6381 (24.9) 1.41 (1.34-1.46) < 0.001 1.35 (1.30-1.40) < 0.001
Widow/widower 31843 (22.4) 1.22 (1.19-1.25) < 0.001 1.15 (1.12-1.18) < 0.001
† Adjusted for age, sex, country of birth, and number of unique nonpsychotropic drug substances purchased during the study period
* Individuals who died or migrated during 2006 were excluded due to missing information on marital status
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utilise antidepressants, but more likely to utilise a poten-
tially inappropriate antidepressant [27]. Women generally
are more knowledgeable than men about health issues, and
physicians describe women as more demanding [32]. This
characteristic could increase women's demands regarding
quality of care. Further, the oldest old were more likely to
utilise several psychotropic drugs, but less likely to utilise
PIP as compared the younger elderly. The oldest old may
have been prescribed these drugs for a long time and may
be unwilling to change to newer drugs. Also, physicians
may be more cautious in prescribing these drugs to the old-
est old due to the increased risk of adverse events.
Individuals who died during the study period were more
likely to utilise three or more psychotropics as well as PIP.
This finding could indicate that these individuals had
poorer health than the survivors, or that utilisation of these
drugs might increase the risk for mortality. However, it is
not possible to make any such conclusions based on the
data available for this study.
The main strength of this study is its population-based
design using national individual-based register data. How-
ever, our data does not include drugs utilised in hospitals.
The most severe cases may therefore be omitted from the
study population, although it is unlikely that individuals are
hospitalised during periods long enough to avoid purchase
of drugs in pharmacies, as the study period was one year.
Further, no information on the actual use of drugs or indica-
tion was available. The cross-sectional design precludes
any conclusions regarding causality. Marital status was
recorded at the end of the study period; consequently, this
information was missing for individuals who died or
migrated during the study period. Those individuals were
excluded from the regression analyses on marital status and
PIP. Since marriage can be related to an increased survival
[33], the association between marital status and PIP may be
underestimated. Further, large sample sizes may increase
the risk of false positive results. However, the regression
analyses performed in the 10% random sample gave similar
results as the original analyses.
Cost-related primary nonadherence is associated with
income [34]. The Swedish Prescribed Drug Register
includes purchased drugs only. Consequently, individuals
who choose not to redeem their prescriptions, because they
cannot afford them or for other reasons, are not present
among the study participants. The restriction of the study
participants to those with at least one purchase of a pre-
scribed psychotropic drug may thus underestimate the rela-
tionship between income level and drug utilisation.
The classification of PIP was based on international
explicit criteria such as Beers' criteria, adapted to Swedish
conditions. The scientific documentation is substantial
regarding the use of explicit criteria [2]. In some cases,
however, drugs classified as potentially inappropriate may
Table 4: Age, sex, and income and utilisation of potentially inappropriate psychotropics among the study participants 
(n = 384346).
PIP, No./Total N (%)† Odds Ratio 
(95% CI)‡




75-79 45788/111787 (41.0) 1 (Reference) 1 (Reference)
80-84 46658/115802 (40.3) 0.95 (0.93-0.96) < 0.001 0.93 (0.91-0.94) < 0.001
85+ 58171/137798 (42.2) 0.95 (0.93-0.96) < 0.001 0.91 (0.90-0.93) < 0.001
Sex
Men 47997/112602 (42.6) 1 (Reference) 1 (Reference)
Women 102620/252786 (40.6) 0.96 (0.95-0.97) < 0.001 0.94 (0.93-0.95) < 0.001
Income*
High 48027/121784 (39.4) 1 (Reference) 1 (Reference)
Middle 51491/124009 (41.5) 1.07 (1.06-1.09) < 0.001 1.08 (1.07-1.10) < 0.001
Low 50983/119233 (42.8) 1.10 (1.08-1.12) < 0.001 1.14 (1.13-1.16) < 0.001
PIP: Potentially inappropriate psychotropic drugs
* Family disposable income for year 2005, adjusted for family size.
† The denominator was adjusted for the proportion of days the population was resident in the country and alive during 2006
‡ Adjusted for the proportion of days resident in the country and alive during 2006
§Adjusted for age, sex, income, country of birth, proportion of days resident in the country and alive during 2006, and number of unique 
nonpsychotropic drug substances purchased during the study period.
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determined, as the Swedish Prescribed Drug Register does
not include the necessary information.
Conclusions
The probability for utilising potentially inappropriate psy-
chotropics, as classified by the NBHW, was higher among
individuals with low income and among the non-married.
These findings indicate that socioeconomic differences
appear to exist in the quality of drug utilisation among
elderly.
The differing levels of health knowledge and behaviour
among the various socioeconomic groups need to be
acknowledged in clinical practice. Efforts to increase good
communication between prescribers and patients striving
for concordance as well as patient empowerment should be
promoted [35]. Further, drug prescribing should not be
biased based on socioeconomic characteristics of the
patient. Due to the increasing number of elderly in the pop-
ulation, an enhanced knowledge about interventions that
effectively increases rational drug use and decreases the
impact of socioeconomic determinants in the quality of care
among the elderly is essential.
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